PixarBio (PixarBio) Other Income (Expense) : $0.00 Mil (TTM As of Sep. 2016)

View and export this data going back to 2016. Start your Free Trial

What is PixarBio Other Income (Expense)?

PixarBio's other income expense for the PixarBio's pretax income for the three months ended in Sep. 2016 was $0.00 Mil. Its other income expense for the trailing twelve months (TTM) ended in Sep. 2016 was $0.00 Mil.

PixarBio Other Income (Expense) Historical Data

The historical data trend for PixarBio's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PixarBio Other Income (Expense) Chart

PixarBio Annual Data

Trend

Dec14

Dec15

Other Income (Expense)

PixarBio Quarterly Data
	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16
Other Income (Expense)	Get a 7-Day Free Trial					-	-	-	-	-

PixarBio Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Sep. 2016 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

PixarBio (GREY:PXRB) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

PixarBio (PixarBio) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PixarBio Corp (GREY:PXRB) » Definitions » Other Income (Expense)

Comparable Companies

Traded in Other Exchanges

N/A

Address

200 Boston Avenue, Suite 1875, Medford, MA, USA, 02155

Website

https://www.pixarbio.com

PixarBio Corp is a specialty pharmaceutical company focused on preclinical and clinical commercial development of therapeutic drug delivery systems for post-operative pain. The company's lead clinical candidate, NeuroRelease is a non-opioid / non-opiate preclinical stage product intended for the treatment of surgical pain, with planned future indications for chronic pain. NeuroRelease blocks nociceptive and neuropathic pain signals arising from temperature and pressure stimuli without affecting motor function, which is intended to allow for effective treatment without delaying post-surgical physical therapy.